Manage Your Liver
Q:

Warning! Think twice before you use DAA treatment.

Warning! Think twice before you use DAA treatment.
A:

In our last post, we brought up the recent findings on extreme liver cancer growth after successful DAA treatment. We are talking about liver cancer of a few centimetres developed within weeks of successful Hep C treatment. These findings are also observed in patients of Gastroenterology. Dr. Roushdi Khalf allah said, “That is a real observation I also faced with my patients in Egypt.” [1]

 

We have also received a number of comments and enquiries from readers who have experienced the same problem mentioned. Many people found this result shocking. This indicates the extreme growth of liver cancer does exist in patients and more importantly, not enough patients are realizing the post treatment risks.

 

The cause of extreme liver cancer growth

The cause of this extreme liver cancer growth is still unclear at this moment, doctors and researchers can only confirm that this type of cancer growth in patients with hepatitis C and cirrhosis is abnormal by saying “A 30% rate over 3 years from initial surgery or ablation is normal. What was surprising to us was that we were observing 4 cm lesions after 12 weeks.” [1]

 

Lead investigator Stefano Brillanti, MD, from the University of Bologna, Italy said that "The hypothesis is that immune surveillance may be reduced too rapidly”. This means that the sudden reduction in virus count and immune surveillance might be the reason behind the growth of abnormal liver cells into large cancers. In another words, he is suggesting that while DAAs can eliminate the viruses, they might have negative impact on your immune system, allowing cancer cells to grow freely.

 

No warnings from doctors, yet.

AASLD (American Association for the Study of Liver Diseases) has already begun asking patients to have regular check-ups to closely monitor liver status even after successful treatment.[2] Most doctors also recommend patients to go back for regular monitoring. But at this stage, it seems that not many doctors realize the potential risks and undoubtedly they are not giving enough warning or information to potential DAA clients.

 

Will everyone get it?

Although an increasing number of  cases are being reported as more patients have received treatment in recent years, it seems that the percentage of patients that will go on to develop extreme cancer still remains relatively low. More concrete figures should be available as more research work is carried out.

 

Would you take the risk?

The big question here is that if you are currently considering treatment, should you go for it? Considering the drawbacks such as the high cost of treatment and uncertain potential risks, the wise move for now might be to allow more time for research and studies and wait for clearer information to become available.

During the wait, it is important to control liver health and liver function. By preventing inflammation and damage caused by hep C virus, liver injury can be prevented and hep C patients can live a healthy life without undergoing anti viral treatment.

 

If you worry about anti-viral treatment or would like to know more about how to maintain healthy liver function and living in harmony with hep C, please send your questions to our support team.

 

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
About 2.7 million persons in the United States are infected with hepatitis C virus in their blood. The majority of these individuals remain asymptomatic for many years following the initial infection, and many people can even live their whole life with hepatitis C virus in their body without knowing they are infected. On the other hand, some carriers will develop chronic hepatitis C, meaning that the virus in their body attacks the liver, causing liver damage with elevated alan
A:
Since the introduction of direct-acting antiviral (DAA) therapy, treatment for hepatitis C (HCV) was revolutionized, as patient outcomes are improved with fewer side effects and high cure rate. However, there is significant debate in the society based on studies that suggest HCV cure does not eliminate risk for hepatocellular carcinoma (HCC) or liver cancer. Other research suggests the possibility of increased risk of developing liver cancer during and after DAA treatment in patients with hep
Hit Questions
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
A:
Hepatitis C viruses share a common characteristic to other chronic liver diseases; it could damage the patients’ liver cells. Hepatitis C patients should focus on stopping or reducing the damage in the liver, and this focus should be the same for other chronic liver diseases e.g. hepatitis B, fatty liver disease, NASH etc. And this is exactly what YHK can do.   YHK can stop liver cells damage caused by hepatitis viruses, and can repair damaged liver cells, to he
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us